Regenxbio (RGNX) Net Cash Flow Growth (5y) (2019 - 2025)
Regenxbio (RGNX) Net Cash Flow Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,071.81 Bn | - |
| 2 | Nanobiotix | 1,925.70 Bn | 1,925.64 Bn | - |
| 3 | Akari Therapeutics | 1,062.88 Bn | 1,062.88 Bn | - |
| 4 | BeOne Medicines | 469.09 Bn | 464.29 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.09 Bn | 115.84 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.32 Bn | 61.57 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.36 Bn | 63.36 Bn | - |
| 8 | Argenx Se | 55.90 Bn | 50.71 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.69 Bn | 34.68 Bn | 959.66 Mn |
| 10 | Regenxbio | 514.18 Mn | 284.11 Mn | 21.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15.99% |
| Sep 30, 2025 | -83.34% |
| Jun 30, 2025 | -32.20% |
| Mar 31, 2025 | 271.40% |
| Dec 31, 2024 | 15.92% |
| Sep 30, 2024 | -15.40% |
| Jun 30, 2024 | -138.86% |
| Mar 31, 2024 | 43.00% |
| Dec 31, 2023 | 22.26% |
| Sep 30, 2023 | -19.51% |
| Jun 30, 2023 | -15.28% |
| Mar 31, 2023 | -25.11% |
| Dec 31, 2022 | -10.30% |
| Sep 30, 2022 | -26.71% |
| Jun 30, 2022 | -23.64% |
| Mar 31, 2022 | -36.16% |
| Dec 31, 2021 | 109.77% |
| Sep 30, 2021 | -70.77% |
| Jun 30, 2021 | -44.68% |
| Mar 31, 2021 | -20.33% |